Form 4: Saba Capital Management Reduces Stake in BlackRock Capital Allocation Term Trust

Saba Capital Management, a 10% owner and director, has decreased its holdings in BlackRock Capital Allocation Term Trust (BCAT) through a series of sales.

Summary

• Saba Capital Management, L.P., along with Boaz Weinstein, has reported changes in their beneficial ownership of BlackRock Capital Allocation Term Trust (BCAT) common stock.
• Between October 10, 2024, and October 14, 2024, Saba Capital Management sold a total of 372,925 shares of BCAT common stock.
• The sales were executed at prices ranging from $16.45 to $16.60 per share.
• Following these transactions, Saba Capital Management's indirect beneficial ownership stands at 15,096,159 shares.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative as a large shareholder is reducing their position. This could indicate a lack of confidence or a shift in investment strategy.

Negatives

• Saba Capital Management has reduced its stake in BlackRock Capital Allocation Term Trust, which could be interpreted negatively by some investors.

Risks

• Continued selling pressure from Saba Capital Management could potentially depress the price of BCAT shares.

Industry Context

Hedge funds like Saba Capital Management frequently adjust their positions in closed-end funds like BCAT to manage their portfolios and capitalize on market opportunities.

Stakeholder Impact

• The reduction in Saba Capital Management's stake could potentially impact shareholder confidence and the market price of BCAT.

Key Dates